Pharmaceutical Supplier – DEA Schedule II Controlled Substance

The contract requires the supply of three units of Morphine Sulfate Injection at a concentration of 10mg/mL, packaged in NEXJECT single-dose format, fully compliant with FDA, DEA, and DLA packaging and labeling regulations. As a Schedule II controlled substance under the DEA, strict adherence to security, documentation, and distribution protocols is mandatory, reflecting the high regulatory scrutiny applied to this class of pharmaceuticals. The product must meet all federal standards for controlled substances, ensuring safe handling, tracking, and chain-of-custody from manufacturer to final delivery point. This is a subcontract issued under the Department of Defense through the Medical Supply Chain Pharm FSA, with performance required at Joint Base Elmendorf-Richardson, Alaska, identified by zip code 99506-4400. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026. The NAICS code 325412 indicates this relates to pharmaceutical preparation manufacturing. All bidding entities must demonstrate capability to meet federal control substance handling requirements and deliver in compliance with DLA’s specific packaging and labeling mandates, with no set-aside provisions specified, meaning the opportunity is open to all qualified suppliers.